A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Public ClinicalTrials.gov record NCT02659397. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Adding ETC-1002 180 mg to Atorvastatin 80 mg Background Therapy in Statin-Treated Patients
Study identification
- NCT ID
- NCT02659397
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Esperion Therapeutics, Inc.
- Industry
- Enrollment
- 68 participants
Conditions and interventions
Conditions
Interventions
- ETC-1002 Drug
- Atorvastatin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2015
- Primary completion
- Jun 30, 2016
- Completion
- Jun 30, 2016
- Last update posted
- Mar 28, 2019
2015 – 2016
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anaheim | California | 92801 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | Northridge | California | 91324 | — |
| Not listed | Clearwater | Florida | 33765 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Miami | Florida | 33126 | — |
| Not listed | Port Orange | Florida | 32127 | — |
| Not listed | Boise | Idaho | 83642 | — |
| Not listed | Chicago | Illinois | 60607 | — |
| Not listed | Springfield | Illinois | 62711 | — |
| Not listed | Louisville | Kentucky | 40213 | — |
| Not listed | Berlin | New Jersey | 08009 | — |
| Not listed | Rapid City | South Dakota | 57701 | — |
| Not listed | Carrollton | Texas | 75006 | — |
| Not listed | West Jordan | Utah | 84088 | — |
| Not listed | Arlington | Virginia | 22203 | — |
| Not listed | Lynchburg | Virginia | 24501 | — |
| Not listed | Richmond | Virginia | 23294 | — |
| Not listed | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02659397, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02659397 live on ClinicalTrials.gov.